Merck & Company (MRK) revenue breakdown

Healthcare · Drug Manufacturers - General · Market cap $362.1B

By segment, Pharmaceutical segment is the largest at 90% of fiscal 2025 revenue; Animal Health grew fastest, 7% a year over 9 years.

By region, United States is the largest at 56% of fiscal 2025 revenue, growing 8% a year over 9 years.

Revenue by segment

Fiscal years, as Merck & Company reports them in its 10-K filings; fiscal 2025 total $64.5B.

Segments2016201720182019202020212022202320242025Share
Pharmaceutical segment$35.2B$35.4B$37.7B$34.1B$36.6B$42.8B$52.0B$53.6B$57.4B$58.1B 90%
Animal Health$3.5B$3.9B$4.2B$4.4B$4.7B$5.6B$5.5B$5.6B$5.9B$6.4B 10%
Other segments$385M$397M$250M$175M—————— —
Other segments————$23M————— —

Revenue by region

Fiscal years, as Merck & Company reports them in its 10-K filings; fiscal 2025 total $65.0B.

Regions2016201720182019202020212022202320242025Share
United States$18.5B$17.4B$18.3B$18.4B$19.6B$22.4B$27.2B$28.5B$32.3B$36.5B 56%
Europe, Middle East and Africa$11.0B$11.5B$12.2B$10.5B$11.5B$13.3B$14.5B$13.3B$14.0B$14.6B 22%
Latin America$2.2B$2.3B$2.4B$2.0B$1.9B$2.2B$2.6B$3.1B$3.5B$3.4B 5%
Asia Pacific (other than Japan and China)$2.5B$2.8B$2.9B$2.1B$2.1B$2.4B$3.6B$3.2B$3.1B$3.0B 5%
Other$1.5B$1.4B$1.0B$1.3B$1.0B$1.2B$2.6B$2.1B$2.6B$2.9B 4%
Japan$2.8B$3.1B$3.2B$2.6B$2.6B$2.7B$3.6B$3.2B$3.3B$2.7B 4%
China$1.4B$1.6B$2.2B$2.2B$2.8B$4.4B$5.2B$6.8B$5.5B$1.9B 3%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for MRK.
Open MRK in Investingly

Questions

Where does Merck & Company make its money?

In fiscal 2025, by segment: Pharmaceutical segment $58.1B, Animal Health $6.4B.

From Merck & Company's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.